Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Paragonimiasis: a view from Columbia.

Iván D Vélez1, Jorge E Ortega, Luz E Velásquez

  • 1Program for the Study and Control of Tropical Diseases (PECET), Antioquia University, Carrera 50a No. 63-85, Medellín, Colombia. id_velez@yahoo.com

Clinics in Chest Medicine
|July 3, 2002
PubMed
Summary

Paragonimiasis, a lung infection from Paragonimus worms, affects millions globally. Diagnosis involves patient history, parasite detection, and tests, with praziquantel as the primary treatment.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Locus coeruleus α-synuclein overexpression induces prodromal Parkinsonian features in mice.

NPJ Parkinson's disease·2026
Same author

Comparative analysis of multiple chronic unpredictable mild stress paradigms in mice: Behavioural and physiological validity.

Neurobiology of stress·2026
Same author

A phase Ib/II clinical study to evaluate the safety and efficacy of topical Arnica tincture to treat non-complicated cutaneous leishmaniasis in Colombia.

PLoS neglected tropical diseases·2025
Same author

Evaluation of behavioural and neurochemical effects of psilocybin in mice subjected to chronic unpredictable mild stress.

Translational psychiatry·2025
Same author

Preclinical drug development: Seeking to improve the reproducibility of results from behavioural experiments in animals.

European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology·2025
Same author

Clinical and preclinical evidence of psilocybin as antidepressant. A narrative review.

Progress in neuro-psychopharmacology & biological psychiatry·2025

Area of Science:

  • Parasitology
  • Infectious Diseases
  • Zoonotic Diseases

Background:

  • Paragonimiasis is a zoonotic parasitic disease caused by Paragonimus trematodes.
  • Infection involves a complex life cycle with snail and crustacean intermediate hosts.
  • Over 40 Paragonimus species exist, with 9 affecting humans in 39 countries.

Purpose of the Study:

  • To summarize the epidemiology, clinical presentation, diagnosis, and treatment of human paragonimiasis.

Main Methods:

  • Review of existing literature on Paragonimus infections in humans.
  • Analysis of epidemiological data on prevalence and at-risk populations.
  • Summary of diagnostic approaches and current therapeutic recommendations.

Main Results:

Related Experiment Videos

  • An estimated 20.7 million people are infected with paragonimiasis, and 195 million are at risk.
  • Clinical symptoms primarily involve the lungs, including cough, thoracic pain, and hemoptysis.
  • Diagnosis relies on clinical history, parasitological examination of sputum/feces, and imaging/immunological tests.

Conclusions:

  • Paragonimiasis poses a significant global health burden, particularly in Asia, Africa, and America.
  • Prompt diagnosis and treatment are crucial to prevent severe complications like life-threatening hemoptysis or pneumothorax.
  • Praziquantel is the current drug of choice for treating paragonimiasis.